Skip Navigation

Advertise|Press|Contact|FAQ|CWConnect

Bookmark/Print/Share

Home » Clinical Trials » Therapeutic Areas
Therapeutic Areas: Cardiology/Vascular Diseases | Hematology | Family Medicine
 Disease Category: High Blood Pressure (Hypertension)
Location: United States, TX

Trial Information

A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study Assessing the Occurence of Major Adverse Cariovascular Events (MACE) in Overweight and Obese Subjects With Cardiovascular Risk Factors Receiving Naltrexone SR/Bupropion SR

If you're a man 45 or older, or a woman 50 or older, need to lose weight, and have heart disease and / or type 2 diabetes with certain heart risk factors, you may qualify for the study. If you participate , you will receive all study-related services at no charge.

Patient Inclusion Criteria:

  • BMI >27 & <50
  • Waist circumference >88cm (women) & >102 cm (men)
  • Cardiovascular Disease
  • Type II Diabetes with at least 2 of the following:
    • Hypertension (controlled with or without pharmacotherapy at <145/95 mm Hg)
    • Dyslipidemia requiring pharmacotherapy
    • Documented low HDL cholesterol (<50 mg/dL in women or <40mg/dL in men) within prior 12 months
    • Current tobacco smoker

Patient Exclusion Criteria:

  • Heart Attack within 3 months of screening
  • Unstable weight within 3 months of screening
  • History of mania or current diagnosis of active psychosis
  • Blood Pressure of >145/95
  • History of seizures
  • Subjects on Wellbutrin
  • New onset of Depression
  • Current use of Opioids

R/D Clinical Research, Inc.
461 This Way
Lake Jackson, TX 77566
Phone: 979-297-3535

View Map

Research Center Information: R/D Clinical Research, Inc.

DISCLAIMER: This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials.